Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Skip to main content
    • by 
    •   22  
      Health CareHong KongEnglandChlamydia pneumoniae
    • by  and +1
    •   28  
      ImmunologyCytokinesMacrophagesChlamydia pneumoniae
    • by 
    •   25  
      ComorbidityChlamydia pneumoniaeInfluenza virusSpain
    • by 
    •   14  
      Chlamydia pneumoniaeHumansFemaleAnimals
    • by 
    •   13  
      MacrophagesChlamydia pneumoniaeBiological SciencesInfection and immunity
    • by 
    •   26  
      ObesityInflammationChlamydia pneumoniaeHumans
    • by 
    •   21  
      AdolescentStreptococcus pneumoniaeChlamydia pneumoniaeIsrael
    • by 
    •   21  
      DentistryHelicobacter pyloriCardiovascular diseaseChlamydia pneumoniae
    • by 
    •   20  
      InflammationHelicobacter pyloriChlamydia pneumoniaeHerpes Simplex
    • by 
    •   25  
      Chlamydia pneumoniaeWestern blottingHumansEscherichia coli
    • by 
    •   20  
      Treatment OutcomeChlamydia pneumoniaeElectrocardiographyHumans
    • by 
    •   7  
      Chlamydia pneumoniaeMiceCholesterolFemale
    • by 
    •   15  
      Multiple sclerosisChlamydia pneumoniaeWestern blottingHumans
    • by 
    •   26  
      InflammationTreatment OutcomeUltrasoundVascular Surgery
    • by 
    •   27  
      Treatment OutcomeAdolescentStreptococcus pneumoniaeChlamydia pneumoniae
    • by  and +1
    •   24  
      Risk assessmentHelicobacter pyloriSocial statusChlamydia pneumoniae
    • by 
    •   23  
      Enzyme InhibitorsFlavonoidsChlamydia pneumoniaeCell Division
    • by 
    •   24  
      Electron MicroscopyIntelligent Transport SystemChlamydia pneumoniaeCell Culture
    • by 
    •   9  
      Helicobacter pyloriChlamydia pneumoniaeClinical MicrobiologyBiological Sciences
    • by 
    •   37  
      ImmunohistochemistryAdolescentChlamydia pneumoniaeBiopsy
    • by 
    •   26  
      RNAChlamydia pneumoniaeClinical MicrobiologyFeasibility Study
    • by 
    •   24  
      ImmunologyGene regulationCardiovascular diseaseChlamydia pneumoniae
    • by 
    •   16  
      Infectious DiseasesCardiovascular diseaseChlamydia pneumoniaeBiological Sciences
    • by 
    •   14  
      Caenorhabditis elegansSequence AnalysisChlamydia pneumoniaeBiological Sciences
    • by 
    •   29  
      GeneticsMass SpectrometryFlow CytometryCardiovascular disease
    • by 
    •   29  
      TechnologyMolecular BiologyMembrane ProteinsSequence Analysis
    • by 
    •   18  
      Electron MicroscopyImmunohistochemistryTransmission Electron MicroscopyVascular Surgery
    • by 
    •   17  
      Flow CytometryFluorescence MicroscopyBiologyMembrane Proteins
    • by 
    •   33  
      ImmunologyAdolescentSTEROIDSEngland
    • by 
    •   18  
      Electron MicroscopyNeurobiologyChlamydia pneumoniaeAmyloid
    • by 
    •   25  
      ImmunologyNeuroimmunologyChlamydia pneumoniaeHumans
    • by 
    •   35  
      Helicobacter pyloriComorbidityCardiovascular RiskLogistic Regression
    • by 
    •   10  
      JapanChlamydia pneumoniaeBiological SciencesEnvironmental Sciences
This is the first study to analyze atheromatous plaques for the presence of bacterial DNA from ten species, including periodontal species and Chlamydia pneumoniae. We examined 129 samples of DNA extracted from atheromas from 29... more
    • by 
    •   26  
      MicrobiologyImmunologyMedical MicrobiologyAtherosclerosis
    • by 
    •   18  
      MicrobiologyVeterinary MicrobiologyChlamydia trachomatisChlamydia pneumoniae
Three touchdown enzyme time release (TETR)-PCR assays were used to amplify different DNA sequences in the variable regions of the 16S and 16S-23S spacer rRNA genes specific for Chlamydia trachomatis, Chlamydia pneumoniae, and Chlamydia... more
    • by 
    •   19  
      Chlamydia trachomatisChlamydia pneumoniaeCell CultureClinical Microbiology
    • by 
    •   17  
      Chlamydia pneumoniaeProspective studiesHumansBlood sampling
Background and Purpose—Several cross-sectional and prospective studies have indicated that high titers of antibodies to Chlamydia pneumoniaeand cytomegalovirus (CMV) are associated with coronary heart disease. The aim of the present study... more
    • by 
    •   32  
      Cardiovascular diseaseChlamydia pneumoniaeStrokeProspective studies
    • by 
    •   20  
      MicrobiologyNatural HistoryAsthmaMolecular Diagnostics
    • by 
    •   18  
      Chlamydia pneumoniaeCell CultureClinical MicrobiologyBiological Sciences
    • by 
    •   9  
      InflammationHelicobacter pyloriMultidisciplinaryChlamydia pneumoniae
    • by 
    •   12  
      ImmunologyComplement activationRetinal Pigment EpitheliumChlamydia pneumoniae
    • by 
    •   20  
      AsthmaChlamydia pneumoniaePathophysiologyHumans
    • by 
    •   16  
      Helicobacter pyloriChlamydia pneumoniaeHumansChronic Disease
    • by 
    •   14  
      Chlamydia pneumoniaeCell CultureBiological SciencesInfection and immunity
    • by 
    •   14  
      Chlamydia pneumoniaeProspective studiesHumansFemale
    • by 
    •   14  
      DNA replicationCorrespondence AnalysisChlamydia trachomatisChlamydia pneumoniae
    • by 
    •   20  
      AsthmaAdolescentLogistic RegressionChlamydia pneumoniae
    • by 
    •   10  
      AsthmaChlamydia pneumoniaeHumansFemale
    • by 
    •   15  
      GeneticsAtherosclerosisCardiovascular diseaseChlamydia pneumoniae